Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Proteomics International Laboratories Ltd. ( (AU:PIQ) ) has provided an announcement.
Proteomics International Laboratories Ltd announced the cessation of 375,000 securities under the ASX code PIQAZ, which expired on November 24, 2025, without being exercised or converted. This announcement may impact the company’s capital structure and could influence stakeholder perceptions regarding the company’s financial strategies and market positioning.
The most recent analyst rating on (AU:PIQ) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Proteomics International Laboratories Ltd. stock, see the AU:PIQ Stock Forecast page.
More about Proteomics International Laboratories Ltd.
Proteomics International Laboratories Ltd operates in the biotechnology industry, focusing on the development of diagnostic tests and analytical services. The company is known for its work in proteomics, which involves the large-scale study of proteins, particularly their structures and functions.
Average Trading Volume: 284,973
Technical Sentiment Signal: Sell
Current Market Cap: A$54.83M
See more insights into PIQ stock on TipRanks’ Stock Analysis page.